Vol. 1, Issue 1, Part A (2019)

CRISPR/Cas9 technology has revolutionized the field of genetic engineering with its precision, efficiency, and versatility. In the pharmaceutical industry, this technology has opened new avenues for drug development, particularly in gene therapy. This paper reviews the applications of CRISPR/Cas9 in pharmaceutical gene editing, discussing its potential in creating targeted therapies for genetic disorders, enhancing drug discovery processes, and developing personalized medicine approaches. The challenges, ethical considerations, and future directions of CRISPR/Cas9 in pharmaceuticals are also examined to provide a comprehensive overview of its impact.